Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 123.0 | 57 | |
RA2159 | EO1428 | 1.0 | uM | 1 | LIF | 112.5 | 60 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | LIF | 420.5 | 42 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 339.0 | 32 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 299.0 | 35 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 399.5 | 54 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 420.0 | 57 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 329.0 | 35 | |
N2586 | EO1428 | 1.0 | uM | 1 | LIF | 125.0 | 61 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | LIF | 309.0 | 54 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 210.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 198.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 319.0 | 40 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 265.0 | 50 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 131.0 | 61 | |
RA2159 | PI103 | 0.1 | uM | 1 | LIF | 105.0 | 40 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | LIF | 599.0 | 41 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 422.0 | 58 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 485.0 | 35 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 564.5 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 569.0 | 35 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 229.5 | 46 | |
N2586 | PI103 | 0.1 | uM | 1 | LIF | 126.0 | 44 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | LIF | 101.0 | 61 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | LIF | 101.5 | 50 |